Table 3.

Multivariable analysis of baseline characteristics associated with RRT avoidance by day 90; pooled intent-to-treat population,^a excluding those patients who died without receiving RRT

Baseline Parametera	Combined Treatment Group (n=412)
	n	OR (95% CI)	P Value
Terlipressin treatment group	412	1.56 (1.02 to 2.39)	0.042
sCr	412	0.52 (0.42 to 0.66)	<0.001
Child-Pugh score	393	0.89 (0.80 to 0.99)	0.040

OR, odds ratio; CI, confidence interval; sCr, serum creatinine.

^aPopulation pooled from OT-0401,¹¹ REVERSE,¹² and CONFIRM¹³ studies.

^bBecause serum creatinine is a component of the Model for End-stage Liver Disease score, despite being significant in the univariable analysis, the Model for End-stage Liver Disease score was not included in the multivariable analysis.